Hi Orion, good post.
Looking back on this and other sites it is interesting to read the expectations of many shareholders a number of years ago and then watch how those expectations continually trundled into the future. always an expectation that next quarter/half/year will be better.
Maybe in many respects this has been influenced by many posters only reporting on the positives with nary a word said about the difficulties being experienced both inside and outside the company in bringing the product to market?
As you say, it is still a 'future' stock, this time many are hanging their hats on FDA approval of IT in the US where in reality IT appears to have made little impression on European sales over the last 12 months.
Anyway, we're an ever hopefull mob, here's hoping this quarterly revenue figure is solidly pointed in the right direction.
Add to My Watchlist
What is My Watchlist?
